TY - JOUR
T1 - Population Health Management for Inflammatory Bowel Disease
AU - Dulai, Parambir S.
AU - Singh, Siddharth
AU - Ohno-Machado, Lucilla
AU - Sandborn, William J.
N1 - Funding Information:
Funding Parambir S. Dulai is supported by the National Institute of Diabetes and Digestive and Kidney Diseases training grant 5T32DK007202. Siddharth Singh is supported by the National Institutes of Health (NIH)/National Library of Medicine training grant T15LM011271 and the American College of Gastroenterology Junior Faculty Development Award and Crohn's and Colitis Foundation of American Career Development Award. Lucilla Ohno-Machado is supported by Patient-Centered Outcomes Research Institute Clinical Data Research Networks (1306-04819) and National Heart, Lung, and Blood Institute's Integrating Data for Analysis, Anonymization and Sharing (NIH U54HL108460).
Publisher Copyright:
© 2018 AGA Institute
PY - 2018/1
Y1 - 2018/1
N2 - Inflammatory bowel diseases (IBDs) are chronic and impose significant, multidimensional burdens on patients and health care systems. The increasing prevalence of IBD will only worsen this problem globally—population health management (PHM) strategies are needed to increase quality of care and population health outcomes while reducing health care costs. We discuss the key components of PHM in IBD. Effective implementation of PHM strategies requires accurate identification of at-risk patients and key areas of variability in care. Improving outcomes of the at-risk population requires implementation of a multicomponent chronic care model designed to shift delivery of ambulatory care from acute, episodic, and reactive encounters, to proactive, planned, long-term care. This is achieved through team care of an activated patient with the help of remote monitoring, clinical information systems, and integrated decision support, with accompanying changes in delivery systems. Performance measurement is integral to any PHM strategy. This involves developing and implementing meaningful metrics of different phases of quality of IBD care and measuring them efficiently using modern clinical information systems. Such an integrated framework of PHM in IBD will facilitate the delivery of high-value care to patients.
AB - Inflammatory bowel diseases (IBDs) are chronic and impose significant, multidimensional burdens on patients and health care systems. The increasing prevalence of IBD will only worsen this problem globally—population health management (PHM) strategies are needed to increase quality of care and population health outcomes while reducing health care costs. We discuss the key components of PHM in IBD. Effective implementation of PHM strategies requires accurate identification of at-risk patients and key areas of variability in care. Improving outcomes of the at-risk population requires implementation of a multicomponent chronic care model designed to shift delivery of ambulatory care from acute, episodic, and reactive encounters, to proactive, planned, long-term care. This is achieved through team care of an activated patient with the help of remote monitoring, clinical information systems, and integrated decision support, with accompanying changes in delivery systems. Performance measurement is integral to any PHM strategy. This involves developing and implementing meaningful metrics of different phases of quality of IBD care and measuring them efficiently using modern clinical information systems. Such an integrated framework of PHM in IBD will facilitate the delivery of high-value care to patients.
KW - Inflammatory Bowel Disease
KW - Population Health
KW - Quality
KW - Value
UR - http://www.scopus.com/inward/record.url?scp=85040658606&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040658606&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2017.09.052
DO - 10.1053/j.gastro.2017.09.052
M3 - Review article
C2 - 29122544
AN - SCOPUS:85040658606
SN - 0016-5085
VL - 154
SP - 37
EP - 45
JO - Gastroenterology
JF - Gastroenterology
IS - 1
ER -